Camlin C.S. auteur aut IRD Seeley J. auteur aut IRD Viljoen L. auteur aut IRD Vernooij E. auteur aut IRD Simwinga M. auteur aut IRD Reynolds L. auteur aut IRD Reis R. auteur aut IRD Plank R. auteur aut IRD Orne-Gliemann J. auteur aut IRD McGrath N. auteur aut IRD Larmarange Joseph auteur aut IRD Hoddinott G. auteur aut IRD Getahun M. auteur aut IRD Charlebois E.D. auteur aut IRD Bond V. auteur aut IRD text journalArticle eng text/pdf reformatted digital access Strengthening universal HIV 'test-and-treat' approaches with social science research The recent publication of new WHO guidelines, including a call for antiretroviral therapy for everyone diagnosed with HIV regardless of CD4 þ cell count and preexposure prophylaxis for people at substantial risk of HIV infection [1], marks an important moment for taking stock of what will be needed to take biomedical HIV prevention approaches to scale, and sustain them. As the author of a recent editorial in The Lancet [2] observes, these guidelines are 'welcome but ambitious. [.. .] No studies exist that address how such a strategy can be executed on a global scale' (p. 1420). We, a multidisciplinary group of social scientists working as part of five large-scale 'universal test-and-treat' (UTT) trials being implemented across six African countries, would argue that successful large-scale expansion of treatment and preexposure prophylaxis will require an indepth understanding of the heterogeneous community and health systems' contexts of the rollout. specialized AFRIQUE 056 30 6 969-970 2016 0269-9370 https://www.documentation.ird.fr/hor/fdi:010066573 10.1097/QAD.0000000000001008 0269-9370 [F B010066573] https://www.documentation.ird.fr/hor/fdi:010066573 https://horizon.documentation.ird.fr/exl-doc/pleins_textes/divers16-03/010066573.pdf IRD - Base Horizon / Pleins textes 2016-03-31 2022-12-08 fdi:010066573 fre